Replies to post #14863 on Relief Therapeutics Holding AG (RLFTF)

[Jama87]

I agree there is a massive international market for meds that can be made cheaply like RLF. Regardless if what happens in US and Europe there is a need for RLF.

Monoclonal antibodies are only going to be available in rich nations. This is reality. They won’t be shipping $3000per dose vials of mABs to developing nations on refrigerated cargo planes.

[Millstone]

Very important point! RLF-100 will be extremely inexpensive and rapid to manufacture on a global scale.